2024年全球重组人源化胶原蛋白行业产品对比报告

Investment Rating - The report does not explicitly state an investment rating for the recombinant human-like collagen industry Core Insights - The recombinant human-like collagen industry is driven by advancements in biotechnology, particularly in gene recombination and synthetic biology, allowing for the precise design and production of collagen with specific amino acid sequences to meet diverse market needs [3][5] - The market for recombinant human-like collagen is primarily fueled by the increasing consumer demand for anti-aging and beauty products, as well as the growing awareness of health [3][5] - The competitive landscape is evolving, with companies possessing core technologies expected to seize more development opportunities as the market becomes more integrated and standardized [3][5] Summary by Sections Introduction to Collagen - Collagen is a natural biopolymer abundant in mammals, constituting about one-third of total protein content, and is classified into animal-derived and recombinant collagen [16][18] - Recombinant collagen is emerging as a superior alternative to animal-derived collagen due to its multiple advantages, including lower immunogenicity and higher biocompatibility [4][16] Current Situation of Recombinant Human-like Collagen Products Industry - The global market for recombinant human-like collagen products has seen significant growth, primarily driven by the Chinese market, with a market size increase from $1.1 million in 2019 to $7.7 million in 2023, reflecting a CAGR of 63.9% [42][44] - The Chinese market for recombinant human-like collagen products is projected to reach ¥245.3 billion by 2028, with a CAGR of 64.6% from 2019 to 2023 [49][50] Competitive Landscape of Recombinant Human-like Collagen Products Industry - The competitive landscape is characterized by a tiered structure, with leading companies like Jinbo Bio and GELITA in the first tier, known for their strong R&D capabilities and brand recognition [56][59] - The second tier includes domestic companies with notable market presence, while the third tier consists of smaller firms with limited resources [62][65] Company Analysis - Key players in the recombinant human-like collagen market include Jinbo Bio, Beitaini, and Duomeikang Bio, which are recognized for their innovative product lines and market strategies [61][62] - The industry is witnessing a rise in the number of approved recombinant collagen products, with a total of 479 approvals in 2023, indicating a robust growth trajectory [49][51]